CRISPR Therapeutics
CRSP
CRSP
403 hedge funds and large institutions have $2.5B invested in CRISPR Therapeutics in 2023 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 154 increasing their positions, 100 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
403
Holders Change
-12
Holders Change %
-2.89%
% of All Funds
6.43%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
45
Increased
154
Reduced
100
Closed
53
Calls
$80.5M
Puts
$91.5M
Net Calls
-$11M
Net Calls Change
-$41M
